Tid Tittel Kategori Vedlegg
20.05.2026
20:55
 Oncoinvent ASA: Grant of share options to member of the Board following AGM -
1
20.05.2026
11:15
 Oncoinvent ASA: Minutes from Annual General Meeting -
1
05.05.2026
10:26
 Oncoinvent ASA: Share capital decrease completed - -
29.04.2026
07:00
 Oncoinvent presents corporate update in live webcast - -
28.04.2026
12:48
 Oncoinvent ASA: Notice of Annual General Meeting -
1
23.04.2026
07:00
 Oncoinvent ASA: Invitation to business update Wednesday 29 April 2026 - -
22.04.2026
16:31
 Oncoinvent ASA: Annual Report for 2025 RAPPORT RAP
2
19.03.2026
07:00
 Oncoinvent secures new patent expanding protection for Radspherin[®] - -
11.03.2026
22:34
 Oncoinvent ASA: Grant of share options to the CEO INSIDEHANDEL INS
1
26.02.2026
07:00
 Oncoinvent ASA: Second half 2025 results RAPPORT RAP
2
17.02.2026
07:00
 Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin[®] at ESGO 2026 - -
29.01.2026
07:00
 Four additional sites open for recruitment in Oncoinvent's Phase 2 trial - -
20.01.2026
10:47
 Oncoinvent ASA: Registration of reverse share split - -
19.01.2026
07:00
 Oncoinvent ASA: Ex. reverse share split and change of ISIN today - -
15.01.2026
10:12
 Oncoinvent ASA - New share capital registered - -
14.01.2026
15:49
 Oncoinvent ASA: Key information relating to the reverse share split and change of ISIN - -
13.01.2026
08:13
 Oncoinvent ASA: Grant of share options to new CFO INSIDEHANDEL INS
1
29.10.2025
17:35
 Merger of BerGenBio and Oncoinvent completed - -
29.10.2025
07:00
 BerGenBio and Oncoinvent - Last day of trading in the shares of Oncoinvent - -
28.10.2025
10:42
 BerGenBio ASA: Approval and publication of prospectus - -
24.10.2025
08:00
 BerGenBio and Oncoinvent - Key Dates for Completion of Merger - -